Biotech and pharma business news, with a focus on the science, people and money that drive the industry.

In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM. Dealmakers, investors, and corporate leaders will gather to chart the course for 2025 and take stock of the landscape, both financial and political.

Dec 11, 2024 · A survey of 77 biotech executives reveals concerns about FDA changes following Donald Trump's reelection. Martin Makary's nomination as FDA chief has eased some worries, while Robert F. Kennedy Jr ...

Dec 13, 2024 · In an at­tempt to con­tin­ue its I&I dom­i­nance be­yond Hu­mi­ra, Skyrizi and Rin­voq, Ab­b­Vie is buy­ing up an­oth­er small au­toim­mune start­up.

Dec 20, 2024 · Applied Therapeutics CEO Shendelman exits; CFO Funtleyder becomes interim CEO after FDA rejects govorestat. Company withdraws EU application for rare disease drug.

Dec 23, 2024 · An affiliate of Deerfield Management Company will acquire Singular Genomics Systems, ending a months-long competition between two suitors that bid up the price of the DNA sequencing company.

Nov 21, 2024 · Novartis is acquiring Kate Therapeutics for $1.1 billion, focusing on gene therapy and neuroscience. CEO Vas Narasimhan and CFO Harry Kirsch indicate future M&A deals will likely stay under $3 ...

Oct 25, 2024 · Elucida Oncology, a clinical-stage biotech led by former Pfizer executive Geno Germano, has shut down, Endpoints News has learned. The New Jersey startup was trying to take a different approach ...

request magic link. If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password.Please note the magic link is one-time ...

Nov 11, 2024 · US reg­u­la­tors gave the green light to Au­to­lus Ther­a­peu­tics’ cell ther­a­py for adult B cell pre­cur­sor acute lym­phoblas­tic leukemia, or B-ALL, that has re­turned or …